Medtronic on Pace for Largest Percent Increase Since November 2020 -- Data Talk

Dow Jones11-18

Medtronic Plc $(MDT)$ is currently at $100.81, up $4.53 or 4.71%

 

--Would be highest close since May 25, 2022, when it closed at $105.54

--On pace for largest percent increase since Nov. 9, 2020, when it rose 9.33%

--Currently up seven of the past eight days

--Currently up two consecutive days; up 5.15% over this period

--Best two day stretch since the two days ending Jan. 14, 2025, when it rose 5.69%

--Up 11.15% month-to-date

--Up 26.2% year-to-date; on pace for best year since 2013, when it rose 39.91%

--Down 25.42% from its all-time closing high of $135.17 on Sept. 8, 2021

--Up 18.6% from 52 weeks ago (Nov. 19, 2024), when it closed at $85.00

--Would be a new 52-week closing high

--Up 26.63% from its 52-week closing low of $79.61 on Dec. 30, 2024

--Traded as high as $102.48; highest intraday level since May 25, 2022, when it hit $106.06

--Up 6.44% at today's intraday high; largest intraday percent increase since Nov. 9, 2020, when it rose as much as 12.22%

--Second best performer in the S&P 500 today

 

All data as of 9:59:28 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

November 18, 2025 10:02 ET (15:02 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment